These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 38769385)

  • 1. Targeting glutamine metabolism improves sarcoma response to radiation therapy in vivo.
    Patel R; Cooper DE; Kadakia KT; Allen A; Duan L; Luo L; Williams NT; Liu X; Locasale JW; Kirsch DG
    Commun Biol; 2024 May; 7(1):608. PubMed ID: 38769385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glutamine metabolism via glutaminase 1 in autosomal-dominant polycystic kidney disease.
    Soomro I; Sun Y; Li Z; Diggs L; Hatzivassiliou G; Thomas AG; Rais R; Parker SJ; Slusher BS; Kimmelman AC; Somlo S; Skolnik EY
    Nephrol Dial Transplant; 2018 Aug; 33(8):1343-1353. PubMed ID: 29420817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GLS-driven glutamine catabolism contributes to prostate cancer radiosensitivity by regulating the redox state, stemness and ATG5-mediated autophagy.
    Mukha A; Kahya U; Linge A; Chen O; Löck S; Lukiyanchuk V; Richter S; Alves TC; Peitzsch M; Telychko V; Skvortsov S; Negro G; Aschenbrenner B; Skvortsova II; Mirtschink P; Lohaus F; Hölscher T; Neubauer H; Rivandi M; Labitzky V; Lange T; Franken A; Behrens B; Stoecklein NH; Toma M; Sommer U; Zschaeck S; Rehm M; Eisenhofer G; Schwager C; Abdollahi A; Groeben C; Kunz-Schughart LA; Baretton GB; Baumann M; Krause M; Peitzsch C; Dubrovska A
    Theranostics; 2021; 11(16):7844-7868. PubMed ID: 34335968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of glutaminase 1-mediated glutaminolysis improves pathological cardiac remodeling.
    Yoshikawa S; Nagao M; Toh R; Shinohara M; Iino T; Irino Y; Nishimori M; Tanaka H; Satomi-Kobayashi S; Ishida T; Hirata KI
    Am J Physiol Heart Circ Physiol; 2022 May; 322(5):H749-H761. PubMed ID: 35275762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glutaminase-1 stimulates the proliferation, migration, and survival of human endothelial cells.
    Peyton KJ; Liu XM; Yu Y; Yates B; Behnammanesh G; Durante W
    Biochem Pharmacol; 2018 Oct; 156():204-214. PubMed ID: 30144404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glutaminase 1 plays a key role in the cell growth of fibroblast-like synoviocytes in rheumatoid arthritis.
    Takahashi S; Saegusa J; Sendo S; Okano T; Akashi K; Irino Y; Morinobu A
    Arthritis Res Ther; 2017 Apr; 19(1):76. PubMed ID: 28399896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain slices from glutaminase-deficient mice metabolize less glutamine: a cellular metabolomic study with carbon 13 NMR.
    El Hage M; Masson J; Conjard-Duplany A; Ferrier B; Baverel G; Martin G
    J Cereb Blood Flow Metab; 2012 May; 32(5):816-24. PubMed ID: 22373647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting glutamine metabolism slows soft tissue sarcoma growth.
    Lee P; Malik D; Perkons N; Huangyang P; Khare S; Rhoades S; Gong YY; Burrows M; Finan JM; Nissim I; Gade TPF; Weljie AM; Simon MC
    Nat Commun; 2020 Jan; 11(1):498. PubMed ID: 31980651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glutaminase and poly(ADP-ribose) polymerase inhibitors suppress pyrimidine synthesis and VHL-deficient renal cancers.
    Okazaki A; Gameiro PA; Christodoulou D; Laviollette L; Schneider M; Chaves F; Stemmer-Rachamimov A; Yazinski SA; Lee R; Stephanopoulos G; Zou L; Iliopoulos O
    J Clin Invest; 2017 May; 127(5):1631-1645. PubMed ID: 28346230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-145 inhibits glutamine metabolism through c-myc/GLS1 pathways in ovarian cancer cells.
    Li J; Li X; Wu L; Pei M; Li H; Jiang Y
    Cell Biol Int; 2019 Aug; 43(8):921-930. PubMed ID: 31115975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting GLS1 to cancer therapy through glutamine metabolism.
    Yu W; Yang X; Zhang Q; Sun L; Yuan S; Xin Y
    Clin Transl Oncol; 2021 Nov; 23(11):2253-2268. PubMed ID: 34023970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upregulation of the Glutaminase II Pathway Contributes to Glutamate Production upon Glutaminase 1 Inhibition in Pancreatic Cancer.
    Udupa S; Nguyen S; Hoang G; Nguyen T; Quinones A; Pham K; Asaka R; Nguyen K; Zhang C; Elgogary A; Jung JG; Xu Q; Fu J; Thomas AG; Tsukamoto T; Hanes J; Slusher BS; Cooper AJL; Le A
    Proteomics; 2019 Nov; 19(21-22):e1800451. PubMed ID: 31231915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting glutaminolysis has antileukemic activity in acute myeloid leukemia and synergizes with BCL-2 inhibition.
    Jacque N; Ronchetti AM; Larrue C; Meunier G; Birsen R; Willems L; Saland E; Decroocq J; Maciel TT; Lambert M; Poulain L; Hospital MA; Sujobert P; Joseph L; Chapuis N; Lacombe C; Moura IC; Demo S; Sarry JE; Recher C; Mayeux P; Tamburini J; Bouscary D
    Blood; 2015 Sep; 126(11):1346-56. PubMed ID: 26186940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dlx-2 and glutaminase upregulate epithelial-mesenchymal transition and glycolytic switch.
    Lee SY; Jeon HM; Ju MK; Jeong EK; Kim CH; Park HG; Han SI; Kang HS
    Oncotarget; 2016 Feb; 7(7):7925-39. PubMed ID: 26771232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting glucose and glutamine metabolism combined with radiation therapy in non-small cell lung cancer.
    Meijer TWH; Peeters WJM; Dubois LJ; van Gisbergen MW; Biemans R; Venhuizen JH; Span PN; Bussink J
    Lung Cancer; 2018 Dec; 126():32-40. PubMed ID: 30527190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of GLS1-mediated glutaminolysis/2-HG/H3K4me3 and GSH/ROS signals in Th17 responses counteracted by PPARγ agonists.
    Miao Y; Zheng Y; Geng Y; Yang L; Cao N; Dai Y; Wei Z
    Theranostics; 2021; 11(9):4531-4548. PubMed ID: 33754076
    [No Abstract]   [Full Text] [Related]  

  • 17. Glutaminase 1 regulates the release of extracellular vesicles during neuroinflammation through key metabolic intermediate alpha-ketoglutarate.
    Wu B; Liu J; Zhao R; Li Y; Peer J; Braun AL; Zhao L; Wang Y; Tong Z; Huang Y; Zheng JC
    J Neuroinflammation; 2018 Mar; 15(1):79. PubMed ID: 29540215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Silencing of glutaminase 1 resensitizes Taxol-resistant breast cancer cells to Taxol.
    Fu A; Yu Z; Song Y; Zhang E
    Mol Med Rep; 2015 Jun; 11(6):4727-33. PubMed ID: 25625774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated expression of glutaminase confers glucose utilization via glutaminolysis in prostate cancer.
    Pan T; Gao L; Wu G; Shen G; Xie S; Wen H; Yang J; Zhou Y; Tu Z; Qian W
    Biochem Biophys Res Commun; 2015 Jan; 456(1):452-8. PubMed ID: 25482439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular targeting of glutaminase sensitizes ovarian cancer cells to chemotherapy.
    Masamha CP; LaFontaine P
    J Cell Biochem; 2018 Jul; 119(7):6136-6145. PubMed ID: 29633308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.